BackLaboratorios Farmaceuticos Rovi, S.A. Overview

Laboratorios Farmaceuticos Rovi, S.A. Receivables

Latest receivables for ROVI.MC: $160M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$160.27M
↑ 17.60% YoYΔ $23.99M vs prior year quarter

Peer trimmed avg / median

Loading

Laboratorios Farmaceuticos Rovi, S.A. Receivables History

Loading

Laboratorios Farmaceuticos Rovi, S.A. vs. peers: Receivables Comparison

Loading

Laboratorios Farmaceuticos Rovi, S.A. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Laboratorios Farmaceuticos Rovi, S.A. (ROVI.MC) FAQ

As of the most recent data (June 2026), ROVI.MC shows a receivables of $160M. That compares with $140M in the prior-year period — up 17.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ROVI.MC's receivables is now $160M (was $140M) — a 17.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Laboratorios Farmaceuticos Rovi, S.A. is outperforming or lagging.

Tracking ROVI.MC's receivables over time shows whether Laboratorios Farmaceuticos Rovi, S.A. is scaling, shrinking, or reshaping that part of the business. The current reading is $160M That compares with $140M in the prior-year period — up 17.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Laboratorios Farmaceuticos Rovi, S.A.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $160M) with ownership activity and broader fundamentals.